Five common and relatively resource-economically treatable disorders, i.e., congenital hypothyroidism (CH), congenital adrenal hyperplasia (CAH), Biotinidase deficiency, Galactosemia, and Glucose 6 phosphate dehydrogenase (G6PD) deficiency [9,10], were selected for screening, consistent with the recommendations of Hinton et al. [11,12]. Here, G6PD is linked to congenital adrenal hyperplasia.